CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 30, 2025		Mar. 31, 2024
Operating Activities:
Net income (loss)	$ (143.0)		$ 47.6
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Depreciation, depletion and amortization	23.5		23.5
Reduction of right of use asset	3.9		3.4
Provision for litigation reserve	215.0		0.0
Restructuring costs	5.5		0.0
Other non-cash items, net	(39.9)		7.2
Net changes in operating assets and liabilities	(69.4)		(25.8)
Net cash (used in) provided by operating activities	(4.4)		55.9
Investing Activities:
Purchases of property, plant and equipment, net	(18.3)		(16.5)
Proceeds from sale of short-term investments	3.1		1.1
Purchases of short-term investments	(4.5)		(1.3)
Other investing activities	(2.1)		0.1
Net cash used in investing activities	(21.8)		(16.6)
Financing Activities:
Proceeds from issuance of short-term debt	14.5		0.0
Repayment of long-term debt	0.0		(3.6)
Repayment of short-term debt	0.0		(9.7)
Purchase of common stock for treasury	(11.5)		(15.0)
Proceeds from issuance of stock under option plan	0.1		2.3
Excess tax benefits related to stock incentive programs	(3.4)		(2.8)
Cash dividends paid	(3.6)		(3.2)
Net cash used in financing activities	(3.9)		(32.0)
Effect of exchange rate changes on cash and cash equivalents	3.6		(8.8)
Net decrease in cash and cash equivalents	(26.5)		(1.5)
Cash and cash equivalents at beginning of period	333.1	[1]	317.2
Cash and cash equivalents at end of period	306.6		315.7
Supplemental disclosure of cash flow information:
Interest paid	19.6		20.3
Income taxes paid	9.8		7.3
Non-cash financing activities:
Treasury stock purchases settled after period end	0.3		0.4
Excise tax charged to equity not paid	$ 0.1		$ 0.0

[1] Condensed from audited financial statements